Uploaded September 2021 | Updated September 2026, 4 days ago

---

In episode 12 of the Immunology Podcast, we chat with Dr. Jeffrey Bluestone, President and CEO of Sonoma Biotherapeutics, a San Francisco and Seattle-based company leveraging the properties of regulatory T cells to create living cell therapies that restore the immune system back to its balanced, fully functioning state. He discusses the company’s research and mission to create therapies that are long-lasting, highly efficacious, and have the potential to slow or prevent autoimmune disease progression and prolong healthy life.

Subscribe today to never miss an episode!
Listen on iTunes: apple.co/3m9mZbF
Listen on Stitcher: bit.ly/2PHJ2ds
Listen on Spotify: spoti.fi/3hp6Iia
Official Website: immunologypodcast.com
Enjoy the other episodes in our full series playlist here: bit.ly/3wxEWo1

0:00 Intro and Roundup
33:01 Guest Interview
#Tregs #Immunotherapy #SonomaBiotherapeutics

This podcast is brought to you by STEMCELL Technologies!
For a full list of products, as well as educational resources, visit our website: stemcell.com
Follow us on Twitter: bit.ly/3jW20Gv
Like us on Facebook: bit.ly/32ern07
Follow us on LinkedIn: bit.ly/32uKovJ
Subscribe to our YouTube channel: bit.ly/32f28ei